 CAMBRIDGE, Mass., Nov. 11, 2021 GLOBE NEWSWIRE -- Checkmate Pharmaceuticals, Inc. NASDAQ: CMPI Checkmate, a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that James Wooldridge, MD, Chief Medical Officer, will present virtually at the Jefferies London Healthcare Conference taking place November 16-19, 2021. The pre-recorded webcast will be available on-demand beginning on Thursday, November 18 at 3:00am ET through Friday, November 19 at 12:00pm ET. Checkmate will also host 1x1 investor meetings during the conference. 